Terri Duran, NP
Nurse Practitioner · Wyoming
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 14
- Since medical school
- 24 years
- Graduated 2002
Offices
14 locations · Spectrum Health Primary Care Partners · 2,283 clinicians in this group
Looking this up.
Hospitals listed: Corewell Health Grand Rapids Hospitals Butterworth. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Terri Duran’s office to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Spectrum HealthGrand Rapids, MIAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Corewell Health, which runs 23 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 115.33 (80.9 to 149.76) · 254 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative sepsis rate: 2.58 (0.13 to 5.03) · 1,980 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.311, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.337, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.322, Oct 2024 – Sep 2025
See every measure and the patient survey for Spectrum Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 10 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 115.33 (80.9 to 149.76) · 254 cases | Better | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 2.58 (0.13 to 5.03) · 1,980 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.311 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.322 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.55 (0.81 to 2.29) · 3,791 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.93 (0.73 to 1.12) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 182 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10 · 252 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 364 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.4 · 766 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.8 · 552 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.8 · 1,083 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 11,083 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.14 (0 to 0.31) · 13,772 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.13 to 0.47) · 14,953 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.03 (1.63 to 4.43) · 4,543 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.43 (1.33 to 3.54) · 2,048 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.61 (1.53 to 3.7) · 4,273 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.76 (3.29 to 10.24) · 1,937 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.25 (0.96 to 3.55) · 1,060 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.85 (0.45 to 1.25) · 12,509 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 87 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.632 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.798 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.781 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12 · 1,026 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 17.9 · 2,126 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.9 · 404 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -10.3 · 912 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.6 · 586 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 1,448 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.6 (3.2 to 6.7) · 265 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9 (6.7 to 11.9) · 265 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.5 · 440 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.7 · 619 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (11.4 to 17.1) · 3,542 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 1,218 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,954 patients answered, 28% of those asked)
| Cleanliness | 2 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 64% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$6,093
Medicare paid this office $6,093 for 74 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 49 | $2,709 | $49 |
| Return visit (30+ min) | 30 | $2,390 | $75 |
Who their Medicare patients are
74 Original Medicare patients in 2024. Average age 72 · Under 65 16% · 85 and older 15% · Women 73% · Also on Medicaid 15% · Health risk score 1.37. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 69% · Depression 38% · Chronic kidney disease 22% · Diabetes 20% · COPD 20% · Coronary heart disease 19% · Cancer 16%.
The office billed $17,981, Medicare allowed $8,196 and paid $6,093; for 117 services of 21 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 74 | 117 | 72 | 1.37 | $17,981 | $6,093 |
| 2019 | 11 | 11 | 74 | 1.11 | $1,045 | $211 |
| 2018 | 45 | 60 | 72 | 1.05 | $5,853 | $2,357 |
| 2017 | 20 | 21 | 68 | 0.72 | $1,495 | $796 |
| 2016 | 36 | 59 | 65 | 0.99 | $1,136 | $584 |
| 2015 | 30 | 44 | 65 | 1.11 | $542 | $453 |
| 2014 | 32 | 54 | 64 | 1.15 | $672 | $501 |
| 2013 | 24 | 37 | 54 | 1.01 | $541 | $342 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2018: 1 service
| Return visit (30+ min) | 39 | $1,990 | $41 |
2016: 1 service
| Hemoglobin a1c level | 27 | $505 | $13 |
2015: 1 service
| Hemoglobin a1c level | 21 | $376 | $13 |
2014: 1 service
| Hemoglobin a1c level | 20 | $402 | $13 |
2013: 1 service
| Hemoglobin a1c level | 13 | $224 | $13 |
Drugs they prescribed that Part D paid
$13,732
Pharmacies billed $13,732 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
530 generic and fewer than 11 brand-name prescriptions · $13,732 in drug cost · 139 antibiotic prescriptions to 106 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Albuterol Sulfate Hfa | 16 | $577 | $36 |
| Gabapentin | 19 | $342 | $18 |
| Omeprazole | 14 | $259 | $18 |
| Amoxicillin-Clavulanate Potass | 24 | $194 | $8 |
| Alendronate | 11 | $166 | $15 |
See all 14 drugs
| Albuterol Sulfate Hfa | 16 | $577 | $36 |
| Gabapentin | 19 | $342 | $18 |
| Omeprazole | 14 | $259 | $18 |
| Amoxicillin-Clavulanate Potass | 24 | $194 | $8 |
| Alendronate | 11 | $166 | $15 |
| Atorvastatin | 14 | $159 | $11 |
| Doxycycline Hyclate | 29 | $156 | $5 |
| Fluticasone Propionate | 15 | $130 | $9 |
| Benzonatate | 17 | $67 | $4 |
| Triamcinolone Acetonide | 11 | $56 | $5 |
| Sulfamethoxazole-Trimethoprim | 28 | $53 | $2 |
| Trazodone | 11 | $52 | $5 |
| Azithromycin | 13 | $40 | $3 |
| Fluconazole | 11 | $38 | $3 |
Year by year
| 2024 | 579 | 274 | None | None | $13,732 |
| 2019 | 104 | 76 | None | None | $3,498 |
| 2018 | 208 | 105 | None | None | $6,862 |
| 2017 | 665 | 100 | 3% (17) | None | $31,985 |
| 2016 | 1,517 | 99 | 6% (94) | 13% | $72,395 |
| 2015 | 1,554 | 118 | 5% (79) | 16% | $107,030 |
| 2014 | 1,593 | 153 | 7% (106) | 17% | $120,209 |
| 2013 | 1,585 | 144 | 10% (158) | 19% | $124,988 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2018: 1 drug
| Ciprofloxacin | 12 | $167 | $14 |
2017: 19 drugs
| Ventolin Hfa | 12 | $1,212 | $101 |
| Bupropion Xl | 14 | $743 | $53 |
| Levothyroxine | 24 | $597 | $25 |
| Atorvastatin | 48 | $518 | $11 |
| Trazodone | 29 | $330 | $11 |
| Omeprazole | 27 | $263 | $10 |
| Gabapentin | 23 | $259 | $11 |
| Lisinopril | 29 | $230 | $8 |
| Lisinopril-Hydrochlorothiazide | 21 | $197 | $9 |
| Amlodipine Besylate | 25 | $189 | $8 |
| Simvastatin | 17 | $113 | $7 |
| Fluticasone Propionate | 13 | $104 | $8 |
| Risperidone | 18 | $102 | $6 |
| Topiramate | 13 | $100 | $8 |
| Citalopram Hbr | 12 | $90 | $8 |
| Atenolol | 12 | $71 | $6 |
| Metformin | 14 | $52 | $4 |
| Tramadol | 13 | $50 | $4 |
| Ibuprofen | 11 | $40 | $4 |
2016: 46 drugs
| Levemir Flextouch | 14 | $6,885 | $492 |
| Aripiprazole | 11 | $5,945 | $540 |
| Symbicort | 12 | $4,089 | $341 |
| Combivent Respimat | 11 | $3,522 | $320 |
| Gabapentin | 68 | $1,501 | $22 |
| Atorvastatin | 100 | $1,062 | $11 |
| Ventolin Hfa | 13 | $980 | $75 |
| Proair Hfa | 15 | $905 | $60 |
| Levothyroxine | 39 | $831 | $21 |
| Omeprazole | 63 | $794 | $13 |
| Bupropion Xl | 14 | $771 | $55 |
| Duloxetine | 13 | $728 | $56 |
| Acetaminophen-Codeine | 50 | $484 | $10 |
| Lisinopril-Hydrochlorothiazide | 59 | $461 | $8 |
| Ziprasidone | 13 | $439 | $34 |
| Lovastatin | 20 | $412 | $21 |
| Oxybutynin Chloride | 13 | $389 | $30 |
| Metoprolol | 16 | $383 | $24 |
| Pravastatin | 13 | $380 | $29 |
| Amlodipine Besylate | 48 | $351 | $7 |
| Meclizine | 16 | $337 | $21 |
| Pioglitazone | 22 | $313 | $14 |
| Baclofen | 13 | $313 | $24 |
| Lisinopril | 48 | $298 | $6 |
| Glimepiride | 15 | $294 | $20 |
| Tramadol | 44 | $246 | $6 |
| Metformin | 64 | $234 | $4 |
| Citalopram Hbr | 22 | $212 | $10 |
| Venlafaxine Hcl Er | 16 | $212 | $13 |
| Amitriptyline | 14 | $209 | $15 |
| Sertraline | 18 | $195 | $11 |
| Naproxen | 18 | $170 | $9 |
| Trazodone | 21 | $168 | $8 |
| Atenolol | 20 | $153 | $8 |
| Losartan | 15 | $140 | $9 |
| Ibuprofen | 27 | $136 | $5 |
| Risperidone | 23 | $136 | $6 |
| Clonazepam | 13 | $135 | $10 |
| Simvastatin | 20 | $122 | $6 |
| Furosemide | 14 | $106 | $8 |
| Topiramate | 18 | $105 | $6 |
| Fluticasone Propionate | 11 | $95 | $9 |
| Hydrochlorothiazide | 14 | $91 | $7 |
| Cyclobenzaprine | 12 | $81 | $7 |
| Lorazepam | 15 | $66 | $4 |
| Meloxicam | 21 | $57 | $3 |
2015: 46 drugs
| Novolog Flexpen | 11 | $12,026 | $1,093 |
| Levemir Flextouch | 18 | $7,881 | $438 |
| Lyrica | 14 | $4,401 | $314 |
| Ziprasidone | 18 | $4,235 | $235 |
| Gabapentin | 63 | $2,442 | $39 |
| Proair Hfa | 30 | $1,973 | $66 |
| Metoprolol | 39 | $1,665 | $43 |
| Omeprazole | 74 | $1,030 | $14 |
| Atorvastatin | 72 | $967 | $13 |
| Duloxetine | 12 | $915 | $76 |
| Valsartan-Hydrochlorothiazide | 15 | $726 | $48 |
| Levothyroxine | 27 | $679 | $25 |
| Pravastatin | 14 | $576 | $41 |
| Amlodipine Besylate | 51 | $527 | $10 |
| Lisinopril-Hydrochlorothiazide | 65 | $504 | $8 |
| Lisinopril | 45 | $465 | $10 |
| Lovastatin | 20 | $462 | $23 |
| Pioglitazone | 18 | $435 | $24 |
| Metformin | 62 | $432 | $7 |
| Gemfibrozil | 15 | $420 | $28 |
| Meclizine | 21 | $405 | $19 |
| Tramadol | 62 | $370 | $6 |
| Topiramate | 22 | $300 | $14 |
| Buspirone | 17 | $293 | $17 |
| Losartan | 19 | $281 | $15 |
| Hydroxyzine Pamoate | 14 | $253 | $18 |
| Glimepiride | 11 | $241 | $22 |
| Acetaminophen-Codeine | 17 | $240 | $14 |
| Venlafaxine Hcl Er | 13 | $221 | $17 |
| Clonazepam | 30 | $192 | $6 |
| Meloxicam | 21 | $173 | $8 |
| Naproxen | 19 | $169 | $9 |
| Simvastatin | 28 | $166 | $6 |
| Sertraline | 14 | $152 | $11 |
| Trazodone | 14 | $151 | $11 |
| Zolpidem | 14 | $148 | $11 |
| Cyclobenzaprine | 20 | $147 | $7 |
| Ibuprofen | 17 | $139 | $8 |
| Furosemide | 20 | $138 | $7 |
| Fluoxetine | 11 | $116 | $11 |
| Paroxetine | 11 | $105 | $10 |
| Lorazepam | 24 | $86 | $4 |
| Dicyclomine | 12 | $62 | $5 |
| Hydrochlorothiazide | 12 | $59 | $5 |
| Risperidone | 11 | $41 | $4 |
| Temazepam | 12 | $36 | $3 |
2014: 40 drugs
| Abilify | 11 | $19,369 | $1,761 |
| Duloxetine | 22 | $6,363 | $289 |
| Advair Diskus | 12 | $4,302 | $359 |
| Gabapentin | 73 | $3,678 | $50 |
| Ziprasidone | 19 | $3,471 | $183 |
| Proair Hfa | 52 | $2,938 | $56 |
| Pioglitazone | 31 | $2,331 | $75 |
| Omeprazole | 86 | $1,420 | $17 |
| Metoprolol | 21 | $1,173 | $56 |
| Atorvastatin | 44 | $779 | $18 |
| Levothyroxine | 36 | $720 | $20 |
| Lovastatin | 24 | $668 | $28 |
| Hydrocodone-Acetaminophen | 38 | $564 | $15 |
| Lisinopril | 68 | $538 | $8 |
| Metformin | 72 | $507 | $7 |
| Tramadol | 67 | $489 | $7 |
| Gemfibrozil | 18 | $457 | $25 |
| Bd Ultra-Fine Pen Needle | 11 | $387 | $35 |
| Simvastatin | 35 | $360 | $10 |
| Amlodipine Besylate | 28 | $331 | $12 |
| Lisinopril-Hydrochlorothiazide | 36 | $318 | $9 |
| Losartan | 17 | $313 | $18 |
| Risperidone | 24 | $267 | $11 |
| Venlafaxine Hcl Er | 17 | $225 | $13 |
| Insulin | 11 | $187 | $17 |
| Trazodone | 24 | $177 | $7 |
| Paroxetine | 18 | $174 | $10 |
| Topiramate | 14 | $172 | $12 |
| Glimepiride | 12 | $166 | $14 |
| Ibuprofen | 18 | $145 | $8 |
| Glipizide | 13 | $141 | $11 |
| Cyclobenzaprine | 21 | $130 | $6 |
| Zolpidem | 25 | $127 | $5 |
| Hydroxyzine Pamoate | 16 | $116 | $7 |
| Alprazolam | 12 | $101 | $8 |
| Clonazepam | 17 | $83 | $5 |
| Temazepam | 12 | $80 | $7 |
| Hydrochlorothiazide | 18 | $78 | $4 |
| Furosemide | 13 | $67 | $5 |
| Lorazepam | 18 | $59 | $3 |
2013: 45 drugs
| Seroquel Xr | 11 | $16,143 | $1,468 |
| Cymbalta | 52 | $14,704 | $283 |
| Abilify | 11 | $11,498 | $1,045 |
| Lidoderm | 13 | $10,151 | $781 |
| Lantus Solostar | 18 | $8,292 | $461 |
| Pioglitazone | 30 | $5,198 | $173 |
| Gabapentin | 79 | $3,995 | $51 |
| Advair Diskus | 11 | $3,355 | $305 |
| Lyrica | 11 | $1,353 | $123 |
| Tramadol Hcl Er | 11 | $1,283 | $117 |
| Proair Hfa | 21 | $1,154 | $55 |
| Hydrocodone-Acetaminophen | 70 | $1,031 | $15 |
| Ropinirole | 21 | $928 | $44 |
| Omeprazole | 69 | $919 | $13 |
| Metoprolol | 13 | $669 | $51 |
| Tramadol | 75 | $611 | $8 |
| Metformin | 68 | $611 | $9 |
| Lisinopril | 69 | $546 | $8 |
| Gemfibrozil | 14 | $538 | $38 |
| Losartan | 16 | $520 | $33 |
| Atorvastatin | 30 | $518 | $17 |
| Levothyroxine | 35 | $489 | $14 |
| Bd Ultra-Fine Pen Needle | 12 | $447 | $37 |
| Simvastatin | 36 | $425 | $12 |
| Lovastatin | 13 | $419 | $32 |
| Lisinopril-Hydrochlorothiazide | 23 | $283 | $12 |
| Paroxetine | 21 | $265 | $13 |
| Trazodone | 31 | $250 | $8 |
| Bupropion Hcl Sr | 14 | $220 | $16 |
| Methocarbamol | 16 | $220 | $14 |
| Topiramate | 11 | $211 | $19 |
| Zolpidem | 32 | $179 | $6 |
| Hydrochlorothiazide | 18 | $175 | $10 |
| Ibuprofen | 23 | $158 | $7 |
| Risperidone | 11 | $144 | $13 |
| Cyclobenzaprine | 14 | $133 | $10 |
| Baclofen | 19 | $131 | $7 |
| Amlodipine Besylate | 17 | $117 | $7 |
| Fluconazole | 15 | $92 | $6 |
| Clonazepam | 17 | $90 | $5 |
| Metoprolol | 15 | $88 | $6 |
| Enalapril Maleate | 14 | $86 | $6 |
| Prednisone | 12 | $61 | $5 |
| Furosemide | 15 | $55 | $4 |
| Amitriptyline | 12 | $43 | $4 |
Professional record
- NPI
- 1134266638
- Licence
- MI 4704202288, TN APN7374
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X); Nurse practitioner (363L00000X)
- Mailing address
- 100 Michigan St Ne # Mc845, Grand Rapids, MI, 49503
- NPI first listed
- 2007-01-31
- NPI last updated
- 2026-06-01
- NPI record certified
- 2026-06-01
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 4254 W Orchid Ln, Chandler, AZ, 85226 · 400 Renaissance Ctr Ste 2600, Detroit, MI, 48243 · 195 Page Mill Rd Ste 103, Palo Alto, CA, 94306